105 related articles for article (PubMed ID: 38749181)
1. RNA epigenetics in pulmonary diseases: Insights into methylation modification of lncRNAs in lung cancer.
Jiang J; Duan M; Wang Z; Lai Y; Zhang C; Duan C
Biomed Pharmacother; 2024 May; 175():116704. PubMed ID: 38749181
[TBL] [Abstract][Full Text] [Related]
2. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.
Cusenza VY; Tameni A; Neri A; Frazzi R
Front Oncol; 2023; 13():1063636. PubMed ID: 36969033
[TBL] [Abstract][Full Text] [Related]
3. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
[TBL] [Abstract][Full Text] [Related]
4. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
Front Genet; 2022; 13():903117. PubMed ID: 35692827
[No Abstract] [Full Text] [Related]
5. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
Wu ZY; Shi ZY
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
[TBL] [Abstract][Full Text] [Related]
6. Novel methylation-related long non-coding RNA clinical outcome prediction method: the clinical phenotype and immune infiltration research in low-grade gliomas.
Li Y; Li X; Yu Z
Front Oncol; 2023; 13():1177120. PubMed ID: 37228500
[TBL] [Abstract][Full Text] [Related]
7. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome.
Liu Y; Zhu J; Ding L
Cell Signal; 2023 Jun; 106():110650. PubMed ID: 36935085
[TBL] [Abstract][Full Text] [Related]
8. Biological Function of Long Non-coding RNA (LncRNA) Xist.
Wang W; Min L; Qiu X; Wu X; Liu C; Ma J; Zhang D; Zhu L
Front Cell Dev Biol; 2021; 9():645647. PubMed ID: 34178980
[TBL] [Abstract][Full Text] [Related]
9. The joint role of methylation and immune-related lncRNAs in ovarian cancer: Defining molecular subtypes and developing prognostic signature.
Gao K; Lian W; Zhao R; Huang W; Xiong J
Transl Oncol; 2023 Aug; 34():101704. PubMed ID: 37257331
[TBL] [Abstract][Full Text] [Related]
10. Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD.
Ma C; Gu Z; Yang Y
J Cell Mol Med; 2024 Apr; 28(8):e18282. PubMed ID: 38647237
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the Divergent Gene Expression Landscapes of m6A/m5C/m1A Methylation Regulators in Hepatocellular Carcinoma Through Single-Cell and Bulk RNA Transcriptomic Analysis.
Liu HT; Rau CS; Liu YW; Hsieh TM; Huang CY; Chien PC; Lin HP; Wu CJ; Chuang PC; Hsieh CH
J Hepatocell Carcinoma; 2023; 10():2383-2395. PubMed ID: 38164510
[TBL] [Abstract][Full Text] [Related]
12. Mutual Correlation between Non-Coding RNA and S-Adenosylmethionine in Human Cancer: Roles and Therapeutic Opportunities.
Mosca L; Vitiello F; Borzacchiello L; Coppola A; Tranchese RV; Pagano M; Caraglia M; Cacciapuoti G; Porcelli M
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209866
[TBL] [Abstract][Full Text] [Related]
13. Dynamic N6-methyladenosine modification of lncRNA modulated by METTL3 during bacterial disease development in an echinoderm.
Zhang S; Shao Y; Li D; Li C
Fish Shellfish Immunol; 2022 May; 124():497-504. PubMed ID: 35483599
[TBL] [Abstract][Full Text] [Related]
14. Using integrated analysis from multicentre studies to identify RNA methylation-related lncRNA risk stratification systems for glioma.
Huang F; Wang X; Zhong J; Chen H; Song D; Xu T; Tian K; Sun P; Sun N; Qin J; Song Y; Ma W; Liu Y; Yu D; Meng X; Jiang C; Xuan H; Qian D; Cai J
Cancer Cell Int; 2023 Aug; 23(1):156. PubMed ID: 37542290
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H
BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma.
Yuan H; Liu J; Zhao L; Wu P; Chen G; Chen Q; Shen P; Yang T; Fan S; Xiao B; Jiang K
Front Immunol; 2021; 12():800268. PubMed ID: 34956238
[TBL] [Abstract][Full Text] [Related]
17. Exploring the interplay between methylation patterns and non-coding RNAs in non-small cell lung cancer: Implications for pathogenesis and therapeutic targets.
Yang M; Hu X; Tang B; Deng F
Heliyon; 2024 Jan; 10(2):e24811. PubMed ID: 38312618
[TBL] [Abstract][Full Text] [Related]
18. Methylated lncRNAs suppress apoptosis of gastric cancer stem cells via the lncRNA-miRNA/protein axis.
Ci Y; Zhang Y; Zhang X
Cell Mol Biol Lett; 2024 Apr; 29(1):51. PubMed ID: 38600465
[TBL] [Abstract][Full Text] [Related]
19. LncRNAs and Chromatin Modifications Pattern m
Vaasjo LO
Front Genet; 2022; 13():866772. PubMed ID: 35368653
[TBL] [Abstract][Full Text] [Related]
20. Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer.
Huang Y; Zhang W; Li Q; Wang Z; Yang X
Sci Rep; 2023 Mar; 13(1):3661. PubMed ID: 36871072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]